River Mercantile TSB better not follow Fat Face
River and Mercantile and Lloyds TSB deals may be key to asset manager and bank floats in 2014
River and Mercantile and Lloyds TSB deals may be key to asset manager and bank floats in 2014
|
|
Fundsmith is seeking to raise between £100m and £250m in order to launch its new Emerging Equities investment trust.
|
|
European equities are no longer obviously inexpensive, argues William Hobbs, but, an attractive dividend yield, a still expected earnings rebound and unevenly dissipating risks could reward investors.
|
|
Pfizers attempt to coax AstraZeneca’s major shareholders into forcing its board to negotiate on a potential takeover ultimately come to nothing
|
|
Fidelity Worldwide Investments has cut the costs of its equity range of index products in an effort to become the dominant player in the space.
|
|
With investors on the lookout for any signs that valuations wont be backed by earnings corporates cannot be seen to be underperforming.
|
|
Blackrock has publicly urged the AstraZeneca board to re-engage with potential buyer Pfizer
|
|
Results of European elections under way today are very unlikely to cause major disruption in markets, fund managers have said
|
|
Periodic mini-crises have forced central banks to take aggressive action to shore up their currencies, often at the expense of the outlook for domestic growth, writes Threadneedle’s Mark Burgess.
|
|
Company planning to raise £12m through London Stock Exchange IPO
|
|
David McFadzean of RBC Wealth Management favours the long game and looks at six funds that help balance a portfolio.
|
|
Rayner Spencer Mills Research is launching fund range and SRI rating services
|
|